Top 2012 Stories

‘Topping Out’ is Symbolic Milestone For New James Cancer Hospital

The final steel beam for completing the 21-story structure of Ohio State’s new James Cancer Hospital and Solove Research Institute was set in place at a May 21 “topping out” ceremony attended by hundreds of enthusiastic observers. This new hospital– the centerpiece of a $1.1 billion Ohio State University Wexner Medical Center Expansion – is designed around a visionary construction model that integrates spaces for research, education and patient care, placing researchers and clinicians in closer working proximity so they can translate more discoveries to innovative care. Michael A. Caligiuri, MD, director of Ohio State’s Comprehensive Cancer Center and CEO of The James, says the hospital, when finished in 2014, will break down walls that historically have divided researchers and clinicians.

Pelotonia Raises More Than $42 Million in 4 Years

Riders and donors in Pelotonia 12, the annual grassroots bicycle tour that generates money for cancer research at the OSUCCC – James, raised a record $16.8 million, a 28-percent increase over the Pelotonia 11 total of $13.1 million. That brings the four-year fundraising total for Pelotonia, which began in 2009, to more than $42million. Pelotonia 12, which took place Aug. 10-12 on routes between Columbus and Kenyon College in Gambier, Ohio, drew a record 6,212 riders, as well as 3,141virtual riders and more than 2,000 volunteers. Among the participants were a record1,635 members of Team Buckeye, the official superpeloton (riding group) for The Ohio State University – a team that included 1,198 riders, 336 virtual riders and101 volunteers. Team Buckeye comprised 84 separate pelotons, whose members collectively raised more than $2.1 million of the Pelotonia 12 total.

Drug Development Institute Boosting Clinical Research

The new Ohio State Drug Development Institute – a collaboration among the OSUCCC – James and the colleges of Medicine, Pharmacy and Business – is creating a cancer drug development pipeline to take promising new compounds through phase II clinical trials. Timothy Wright, director of the Drug Development Institute, says the endeavor holds great potential to benefit cancer patients in Ohio and beyond. Wright says his role is to facilitate the work of the nearly 300 cancer researchers at the OSUCCC – James and to work with Ohio State’s Technology Commercialization Office “to optimize value from our research inventions.” He notes that two targeted agents invented by OSUCCC – James investigators are already in early-phase clinical trials, and more “are in the pipeline.

OSUCCC – James Earns NCI Phase II Contract Renewal

The National Cancer Institute (NCI) awarded the OSUCCC – James a phase II clinical
trials contract that could be worth more than $8 million over five years if fulfilled to capacity. Principal investigator Miguel Villalona, MD, says the money, a renewal of a similar $3 million contract the NCI awarded to Ohio State in 2006, will enable the OSUCCC – James to conduct phase II clinical trials on NCI-sponsored agents as the lead institution in a consortium that includes Case Western Reserve Comprehensive Cancer Center/Cleveland Clinic, Georgetown University Lombardi Comprehensive Cancer Center, and Roswell Park Cancer Institute as collaborators. These trials will help scientists evaluate biologic effects of experimental anticancer agents and determine clinically relevant outcomes/correlates of drug efficacy and toxicity. The OSUCCC – James and collaborators constitute one of only seven consortia holding NCI phase II contracts.

Nursing Unveils New Professional Practice Model

OSUCCC – James Nursing unveiled a Nursing Professional Practice Model (PPM)that “artistically portrays how our vision, mission and values come to life.” Nursing leaders say the PPM, inspired by the ancient mandala (see image, right), affirms sense of professionalism and commitment to excellence; guides practice and depict how James nurses contribute to the hospital’s patient care, education and research mission; and supports the OSUCCC – James vision of creating a cancer-free world. The PPM, which evolved through a grassroots approach that involved nurses in all roles, contains five core components: Leadership and Governance; Patient Care; Innovation and Research; Professional Relationships; Development and Recognition

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: